|
DDNEWS Special Reports
Throughout the year, we will examine specific trends or
current topics of importance to the drug discovery arena. These Special Reports
dissect the latest news involving global partnerships and business deals and
take a closer look at such issues as informatics, diagnostics, automation and
instrumentation, ‘omics and systems biology, research and development, government
issues and the growing contract research services market.
Our Special Report schedule for 2013 is:
January: Vaccine Development
March/April: Cancer Research
June: 60th Anniversary of DNA
July/August/September: Stem Cell Research
November: Medicinal Chemistry For more information about our upcoming reports, contact Randall Willis, DDNEWS' Features Editor, at willis@ddn-news.com.
Vaccine Development No vaccine is an island Adjuvant advances, international interactions and personalized preventions are transforming the world of vaccinology Personalized Medicine
CDx market sees strong growth despite regulatory,
development burdens
Drug RepurposingEverything old is new again
Drug repositioning provides cost savings, shortcuts
Going for multiple shots on goal Drugmakers seek more than one application for compounds in
early phase of development Cell BiologyFor personalized medicine to truly arrive, cell biology may
be more important in the end than genomics
Trends in Cell Biology: DDNEWS Interview with Dr. V. Jo Davisson
Expert in the cell biology field identifies some of the themes dominating this growing research area Stem Cell ResearchThe promise, the
pitfalls and a paradigm shift
The complex history of stem cell research yields hope for
improved human health, unresolved concerns
Just like stem cells, global research efforts with them are
many and varied
DDNEWS Editorial
Roundtable: Ethics and stem cell research
Researchers discuss the ethical, moral and scientific concerns associated with stem cell research In new survey, we try to get to the bottom of perceptions on stem cells
and other R&D efforts Staking a claim Growing stem cell market entices Big Pharma to harness its power for drug screening, toxicity testing Blazing the trail
Backed by strong venture capital funding, biotechs organize around promise of stem cell research A roundup of North America's top five
academic research institutions in the stem cell arena
Tools of the trade
Life science tool providers provide
constant support to ever-evolving stem cell research community
Epigenetics: Half of the picture
Science plugs stem cells into epigenetic opportunities that control various disease states Regenerating interest in stem cell medicine Stem cell technologies still hold potential to replace organs and tissues, but initial hype has been toned down Drug Delive ry
Drug delivery: Why getting there isn’t half the fun How the “fizz, fizz” part is all too often missing in today’s new drug formulations Screening Technology
Research at the speed of
light
High-throughput screening technology leads to advances in drug discovery Billions of screens have produced … what? Critics of high-throughput
screening ask: Is the approach of building a bigger haystack really the best
way to find more needles?
Label-free: The way
to be?
In this exclusive editorial roundtable discussion, a panel of companies producing label-free technologies for drug discovery opine on trends, future of this growing market Plus: Label-free technology primer A partly impartial and partly commercial introduction to the state of the tech for label-free assays Trends in Cancer
Research‘Good enough’ is no longer good enough
Aiming beyond the standard of care in oncology Pharmacogenomics harnesses
power of prediction, personalization Branch of pharmacology stands
at the precipice of the era of personalized medicine in cancer treatment
Getting down to basics Researchers dig deep into the
genome, not just to establish the causes of cancer, but also the best
approaches to treatment Two are better than one The challenges and rewards of developing companion diagnostics for cancer treatment Biomarkers: How good a test are they? Tracing biological fingerprints, known as biomarkers, can be a valuable and rapidly growing part of medical research Report: Cancer diagnostics market could hit $90 million by 2014 Market research publisher Kalorama Information predicts a $90 million market for pharmacodiagnostics, tests that determine whether a treatment matches the individual patient, by 2014 Knowledge is power Breakthroughs in cancer research are frequently pioneered in the halls of academia Federal funding and the 40 years’ war on cancer Government bureaucracy may be thwarting funding of breakthrough cancer research Financing the fight
Foundations are at ground zero in the battle against cancer Pink ribbons and
yellow bracelets
The strange paradox of cancer’s persistence in the face of public optimism about progress toward a cure |
|
||
|
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|